Quantity size:
0.2ml
Concentration:
1mg/ml 磷脂酰肌醇3磷酸激酶5Ⅲ型抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Phosphorylated derivatives of phosphatidylinositol (PtdIns) regulate cytoskeletal functions, membrane trafficking, and receptor signaling by recruiting protein complexes to cell- and endosomal-membranes. Humans have multiple PtdIns proteins that differ by the degree and position of phosphorylation of the inositol ring. This gene encodes an enzyme (PIKfyve; also known as phosphatidylinositol-3-phosphate 5-kinase type III or磷脂酰肌醇3磷酸激酶5Ⅲ型抗体 PIPKIII) that phosphorylates the D-5 position in PtdIns and phosphatidylinositol-3-phosphate (PtdIns3P) to make PtdIns5P and PtdIns(3,5)biphosphate. The D-5 position also can be phosphorylated by type I PtdIns4P-5-kinases (PIP5Ks) that are encoded by distinct genes and preferentially phosphorylate D-4 phosphorylated PtdIns. In contrast, PIKfyve preferentially phosphorylates D-3 phosphorylated PtdIns. In addition to being a lipid kinase, PIKfyve also has protein kinase activity. PIKfyve regulates endomembrane homeostasis and plays a role in the biogenesis of endosome carrier vesicles from early endosomes. Mutations in this gene cause corneal fleck dystrophy (CFD); an autosomal磷脂酰肌醇3磷酸激酶5Ⅲ型抗体 dominant disorder characterized by numerous small white flecks present in all layers of the corneal stroma. Histologically, these flecks appear to be keratocytes distended with lipid and mucopolysaccharide filled intracytoplasmic vacuoles. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, May 2010]
Also known as:
1-phosphatidylinositol-3-phosphate 5-kinase; 1 phosphatidylinositol 3 phosphate 5 kinase; 1 phosphatidylinositol 4 phosphate 5 kinase; CFD; FAB1; FYVE finger containing phosphoinositide kinase; KIAA0981; MGC40423; p235; Phosphatidylinositol 3 phosphate 5 kinase type III;磷脂酰肌醇3磷酸激酶5Ⅲ型抗体 Phosphatidylinositol 3 phosphate/phosphatidylinositol 5 kinase type III; Phosphatidylinositol 4 phosphate 5 kinase type III; Phosphoinositide kinase, FYVE finger containing; PIKFYVE; PIP5K; PIPkin III; PtdIns(4)P 5 kinase; Type III PIP kinase; ZFYVE29; Zinc finger, FYVE domain containing 29.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Sheep, .
●
磷脂酰肌醇3磷酸激酶5Ⅲ型抗体Immunogen: KLH conjugated synthetic peptide derived from human PIP5K3.
●
Predicted Molecular Weight: 237kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user
kl021Ra01睫状神经营养因子(CNTF)多克隆抗体Polyclonal Antibody to Ciliary Neurotrophic Factor (CNTF)
kl021Rb51睫状神经营养因子(CNTF)多克隆抗体Polyclonal Antibody to Ciliary Neurotrophic Factor (CNTF)
kl022Bo01血管内皮细胞蛋白C受体(PROCR)多克隆抗体Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Ga01血管内皮细胞蛋白C受体(PROCR)多克隆抗体Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Hu01血管内皮细胞蛋白C受体(PROCR)多克隆抗体Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Mu01血管内皮细胞蛋白C受体(PROCR)多克隆抗体Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Po01血管内皮细胞蛋白C受体(PROCR)多克隆抗体Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Ra01血管内皮细胞蛋白C受体(PROCR)多克隆抗体Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl024Bo01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Hu01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Mu01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Ra01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl025Bo01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Eq01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Gu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Hu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Mu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Ra01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Si01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl026Hu01趋化因子C-C-基元配体3样蛋白1(CCL3L1)多克隆抗体Polyclonal Antibody to Chemokine C-C-Motif Ligand 3 Like Protein 1 (CCL3L1)
kl026Mu01趋化因子C-C-基元配体3样蛋白1(CCL3L1)多克隆抗体Polyclonal Antibody to Chemokine C-C-Motif Ligand 3 Like Protein 1 (CCL3L1)
kl027Hu01红细胞生成素受体(EPOR)多克隆抗体Polyclonal Antibody to Erythropoietin Receptor (EPOR)
kl027Ra01红细胞生成素受体(EPOR)多克隆抗体Polyclonal Antibody to Erythropoietin Receptor (EPOR)
kl029Bo01E选择素(SELE)多克隆抗体Polyclonal Antibody to Selectin, Endothelium (SELE)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话